Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma
Authors:
- John R GoldblumJGJohn R Goldblum
- Steven D BillingsSBSteven D Billings
- 1 October 2013
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 26 (10) , 1382-1389
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sox2 Protein Expression is an Independent Poor Prognostic Indicator in Stage I Lung AdenocarcinomaAmerican Journal of Surgical Pathology, 2010
- Perianal basal cell Carcinoma - An unusual site of occurrenceIndian Journal of Dermatology, 2010
- p16 Gene Expression in Basal Cell CarcinomaArchives of Medical Research, 2008
- Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cellsNature Cell Biology, 2007
- Sox2: a possible driver of the basal-like phenotype in sporadic breast cancerLaboratory Investigation, 2007
- Perianal Basal Cell CarcinomaJournal of Cutaneous Medicine and Surgery, 2002
- bcl‐2 protein expression in aggressive and non‐aggressive basal cell carcinomasJournal of Cutaneous Pathology, 2000
- bcl-2 Protein Expression and Correlation with the Interchromosomal 14;18 Translocation in Cutaneous Lymphomas and PseudolymphomasJournal of Investigative Dermatology, 1994
- Monoclonal Antibody Ber EP4 Distinguishes Basal-Cell Carcinoma from Squamous-Cell Carcinoma of the SkinThe American Journal of Dermatopathology, 1993
- FIVE CASES OF BASAL‐CELL CARCINOMA OF THE VULVABJOG: An International Journal of Obstetrics & Gynaecology, 1956